Gene · 8239
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Who Benefits Most from the Family Education and Support Program in Cape Verde? A Cluster Analysis. | Children (Basel) | 2024 | 39062230 | PubTator, text mining | PubMed |
| BCORL1, POF1B, and USP9X copy number variation in women with idiopathic diminished ovarian reserve. | J Assist Reprod Genet | 2024 | 38995507 | PubTator, text mining | PubMed |
| USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration. | Transl Oncol | 2024 | 38964032 | PubTator, text mining | PubMed |
| Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway. | Sci Adv | 2024 | 38959315 | PubTator, text mining | PubMed |
| Molecular changes driving low-grade serous ovarian cancer and implications for treatment. | Int J Gynecol Cancer | 2024 | 38950921 | PubTator, text mining | PubMed |
| Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous Carcinoma. | Int J Gynecol Pathol | 2024 | 38914014 | PubTator, text mining | PubMed |
| Excitonic Configuration Interaction: Going Beyond the Frenkel Exciton Model. | J Chem Theory Comput | 2024 | 38885637 | PubTator, text mining | PubMed |
| Circ-USP9X accelerates deep vein thrombosis after fracture by acting as a miR-148b-3p sponge and upregulates SRC kinase signaling inhibitor 1. | Clinics (Sao Paulo) | 2024 | 38878321 | PubTator, text mining | PubMed |
| Long noncoding RNA UCA1 promotes the chondrogenic differentiation of human bone marrow mesenchymal stem cells via regulating PARP1 ubiquitination. | Stem Cells | 2024 | 38829368 | PubTator, text mining | PubMed |
| USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase. | J Biomed Sci | 2024 | 38802791 | PubTator, text mining | PubMed |
| Characteristic craniofacial defects associated with a novel USP9X truncation mutation. | Hum Genome Var | 2024 | 38755172 | PubTator, text mining | PubMed |
| Deubiquitinases in muscle physiology and disorders. | Biochem Soc Trans | 2024 | 38716888 | PubTator, text mining | PubMed |
| Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma. | J Invest Dermatol | 2024 | 38677662 | PubTator, text mining | PubMed |
| Notoginsenoside Ft1 inhibits colorectal cancer growth by increasing CD8+ T cell proportion in tumor-bearing mice through the USP9X signaling pathway. | Chin J Nat Med | 2024 | 38658096 | PubTator, text mining | PubMed |
| Screening of premature ovarian insufficiency associated genes in Hungarian patients with next generation sequencing. | BMC Med Genomics | 2024 | 38649916 | PubTator, text mining | PubMed |
| Schwann cell-derived extracellular vesicles promote memory impairment associated with chronic neuropathic pain. | J Neuroinflammation | 2024 | 38632655 | PubTator, text mining | PubMed |
| Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment. | Biochim Biophys Acta Rev Cancer | 2024 | 38582329 | PubTator, text mining | PubMed |
| Retracted: Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease. | Biomed Res Int | 2024 | 38550085 | PubTator, text mining | PubMed |
| EVATOM: an optical, label-free, machine learning assisted embryo health assessment tool. | Commun Biol | 2024 | 38443460 | PubTator, text mining | PubMed |
| Investigating the mechanisms underlying resistance to chemoterapy and to CRISPR-Cas9 in cancer cell lines. | Sci Rep | 2024 | 38443409 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8239/papers?page=6